Literature DB >> 26044811

Comorbidity between chronic obstructive pulmonary disease and type 2 diabetes: A nation-wide cohort twin study.

Howraman Meteran1, Vibeke Backer2, Kirsten Ohm Kyvik3, Axel Skytthe4, Simon Francis Thomsen2.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality and is associated with several systemic diseases, such as type 2 diabetes. It has been suggested that comorbidity between COPD and type 2 diabetes is due to shared genetic factors. AIM: To examine the relationship between type 2 diabetes and chronic bronchitis and COPD in adult twins, and to examine to what extent comorbidity between these diseases is explained by shared genetic or environmental factors.
METHODS: Questionnaire data on chronic bronchitis and hospital discharge data on diagnosed COPD in 13,649 twins, aged 50-71 years, from the Danish Twin Registry were cross-linked with hospital discharge diagnosis data on type 2 diabetes from the Danish National Patient Registry.
RESULTS: The risk of type 2 diabetes was higher in persons with symptoms of chronic bronchitis than in those without symptoms (3.5 vs. 2.3%), OR = 1.57 (1.10-2.26), p = 0.014, and in individuals with diagnosed COPD than in those without the diagnosis (6.6 vs. 2.3%), OR = 2.62 (1.63-4.2), p < 0.001. The results were significant after adjusting for age, sex, smoking, and BMI. Correlations between genetic effects on chronic bronchitis and type 2 diabetes, and between genetic effects on diagnosed COPD and type 2 diabetes, respectively, were 0.33 (0.00-0.79), p = 0.103, and 0.43 (0.00-0.98), p = 0.154. Non-shared environmental correlations between chronic bronchitis and type 2 diabetes were -0.13 (-0.43 to 0), p = 0.498 and diagnosed COPD and type 2 diabetes -0.12 (-0.48 to 0), p = 0.665.
CONCLUSIONS: Patients with chronic bronchitis or COPD have an increased risk of type 2 diabetes independent of sex, age, smoking and BMI. The genetic correlation between type 2 diabetes and chronic bronchitis was 33% and type 2 diabetes and COPD was 43%, however neither were statistically significant. The increased risk of type 2 diabetes should be accommodated in the management of patients with chronic bronchitis or COPD.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  COPD; Chronic bronchitis; Comorbidity; Epidemiology; Twin studies; Type 2 diabetes

Mesh:

Year:  2015        PMID: 26044811     DOI: 10.1016/j.rmed.2015.05.015

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Preview of highlighted presentations from the European Respiratory Society' clinical assembly.

Authors:  Nicolas Kahn; Lowie E G W Vanfleteren; Georgios Kaltsakas; Vasileios Andrianopoulos; Daniela Gompelmann; Corina de Jong; Felix J F Herth
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy.

Authors:  Kejia Chen; Jiamin Yan; Ling Wu; Xingbo Gu
Journal:  Med Sci Monit       Date:  2022-05-17

3.  [The role of counterinsular hormones in the regulation of glucose homeostasis and the pathogenesis of type 2 diabetes mellitus in COPD].

Authors:  V I Kobylyansky
Journal:  Probl Endokrinol (Mosk)       Date:  2021-02-17

4.  Chronic Obstructive Pulmonary Disease Is Associated with Epigenome-Wide Differential Methylation in BAL Lung Cells.

Authors:  Jonas Eriksson Ström; Simon Kebede Merid; Jamshid Pourazar; Anders Blomberg; Anne Lindberg; Mikael V Ringh; Michael Hagemann-Jensen; Tomas J Ekström; Annelie F Behndig; Erik Melén
Journal:  Am J Respir Cell Mol Biol       Date:  2022-06       Impact factor: 7.748

5.  The outcome and the influencing factors of the age of onset in post-mortem of chronic bronchitis patients: a retrospective study.

Authors:  Linyun Zhu; Zhenhua Ni; Xuming Luo; Zhuhua Zhang; Shiqiang Wang; Ziyu Meng; Xiandong Gu; Xiongbiao Wang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-21

6.  Prevalence of different comorbidities in chronic obstructive pulmonary disease among Shahrekord PERSIAN cohort study in southwest Iran.

Authors:  Fatemeh Zeynab Kiani; Ali Ahmadi
Journal:  Sci Rep       Date:  2021-01-15       Impact factor: 4.379

7.  Chronic obstructive pulmonary disease, lung function and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies.

Authors:  Yang Peng; Guo-Chao Zhong; Lingxiao Wang; Lijuan Guan; Ao Wang; Kai Hu; Jing Shen
Journal:  BMC Pulm Med       Date:  2020-05-11       Impact factor: 3.317

8.  Metformin use is associated with a low risk of tuberculosis among newly diagnosed diabetes mellitus patients with normal renal function: A nationwide cohort study with validated diagnostic criteria.

Authors:  Ming-Chia Lee; Chen-Yuan Chiang; Chih-Hsin Lee; Cheng-Maw Ho; Chia-Hao Chang; Jann-Yuan Wang; Shih-Ming Chen
Journal:  PLoS One       Date:  2018-10-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.